Dr. Nordenberg is the co-founder and Executive Director for the Medical Device Innovation, Safety, and Security Consortium (MDISS). He is a member of the Health Information Technology Standards Federal Advisory Committee (ONC, HHS); a member of the FDA’s National Evaluation System for Technology (NEST) Planning Board; and co-chairs the Medical Device Security Information Sharing Council for the National Health Information Sharing and Analysis Center (NH-ISAC). Dr. Nordenberg is CEO of Novasano Health and Science. He has extensive experience in the domains of healthcare strategy and operations, health information technology, FDA regulated industries, research network development, public-private partnership development, and emergency preparedness.
Dr. Nordenberg also cofounded and co-directs the public-private partnership, TBResist. Prior to Novasano, Dr. Nordenberg was a managing director in the health care practice of PricewaterhouseCoopers. Dr. Nordenberg held various positions at CDC including Chief Information Officer (CIO) and Associate Director, National Center for Infectious Diseases (NCID). He was detailed to the Office of the National Coordinator for Health Information Technology at HHS. Dr. Nordenberg was a member of the Science and Technology Review Subcommittee of the Science Advisory Board of the FDA. Prior to CDC, Dr. Nordenberg was a founding executive of a company that launched VeriSign affiliates in Latin America and Asia and prior to that he was faculty in the Emory School of Medicine where he founded and directed the Office of Medical Informatics for the Emory University Children’s Center and was the physician lead at Egleston Children’s Hospital.
Dr. Nordenberg is a board certified pediatrician, medical epidemiologist, and medical informaticist. He received a BS in Microbiology from the University of Michigan, his medical degree from Northwestern University, completed his training in pediatrics at McGill University, Montreal Children’s Hospital, and his fellowship in epidemiology and public health in the Epidemic Intelligence Services Program at the Centers for Disease Control with a focus on “big data”.